Skip to main content
. 2009 Apr 24;4(4):e5323. doi: 10.1371/journal.pone.0005323

Figure 3. Metnase levels predict breast cancer cell sensitivity to Topo IIα inhibitors.

Figure 3

Cells stably transfected with vector control, or Metnase shRNA were treated with VP-16 (A) or adriamycin (B) and colony survival was measured as described. Values are averages ±SEM for three determinations. (C) Cells transfected with control (shGFP) or Metnase shRNA were treated with 1 µM adriamycin for 24 hrs and apoptosis (annexin-V) and cell death (propidium iodide) were analyzed by FACS. Values are averages (+SEM) for three determinations.